Skip to content

Mechanism of multi-target synergistic stimulation of the primary motor area-caudate nucleus circuit to improve upper limb motor function in stroke patients

Mechanism of multi-target synergistic stimulation of the primary motor area-caudate nucleus circuit to improve upper limb motor function in stroke patients

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063645
Enrollment
Unknown
Registered
2022-09-13
Start date
2022-09-13
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Part ?: Group 1:Paired associative stimulation
Part ?: Group 2:Sham stimulation

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Part I: (1) 18-70 years old, unlimited gender; (2) No neurological disease, no serious bone, joint or muscle diseases, no obvious cognitive impairment, no serious organ disease or serious mental disease; (3) right-handed. Part ?: (1) Ischemic/hemorrhagic stroke diagnosed by CT/MRI; (2) 30-70 years old, unlimited gender; (3) Primary education level or above; (4) First onset, course of disease within 1 year, unilateral hemiplegia; (5) No obvious cognitive impairment, mini-mental State Examination (MMSE) : primary education level: >20; Middle education level or ablove: >24; (6) Unilateral upper extremity motor dysfunction, the upper extremity of Fugl-Meyer Assessment Scale (FMA) : 0-65; (7) right-handed.

Exclusion criteria

Exclusion criteria: Part I: (1) There are contraindications, such as pacemaker, cardiac stent, claustrophobia, etc.; (2) Participated in or is participating in other clinical projects one month before enrollment; (3) There are contraindications to transcranial magnetic stimulation, such as cochlear implantation, history of epilepsy, metal implantation in vivo; (4) Pregnant or lactating women. Part ?: (1) Unstable vital signs in the acute phase; (2) Aphasia, hearing impairment and other people who are unable to communicate with others; (3) Severe bone, joint and muscle diseases; (4) Patients with serious organ diseases and mental disorders; (5) There are contraindications, such as pacemaker, cardiac stent, claustrophobia, etc.; (6) Participated in or is participating in other clinical projects one month before enrollment; (7) There are contraindications to transcranial magnetic stimulation, such as cochlear implantation, history of epilepsy, metal implantation in vivo; (8) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Finger tapping test;Fugl-Meyer assessment scale;

Secondary

MeasureTime frame
Neuroelectrophysiological indexes;Magnetic Resonance Imaging;Grip strength test;Simple test for evaluating hand function;Modified Barthel Index;stroke-specific quality of life;

Countries

China

Contacts

Public ContactWu Jia-Jia

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

wujiajia@shutcm.edu.cn15161769295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026